Literature DB >> 9854584

Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids.

P M Kirshbom1, A R Kherani, M W Onaitis, J M Feldman, D S Tyler.   

Abstract

BACKGROUND: Carcinoids are rare neuroendocrine tumors typically arising in the gastrointestinal tract. A significant percentage of these tumors present as metastatic disease of unknown primary site. The aim of this study was to better define the functional and clinical characteristics of carcinoids of unknown primary (CUP) site.
METHODS: This study examines the hormonal activity, clinical characteristics, and survival of 434 patients with carcinoids originating in the foregut, midgut, hindgut, or unknown location. The 143 patients with CUP were compared with the other groups with regard to presenting characteristics, diagnostic tests and therapeutic modalities used, hormonal activity, and survival.
RESULTS: The hormone levels (urinary 5-hydroxyindoleacetic acid and serotonin, serum and platelet serotonin) of CUP were not significantly different from midgut carcinoids with metastatic disease. Although survival with CUP was shorter than with carcinoids with identified primaries (10-year survivals of 22% vs 62%, 50%, and 48% for foregut, midgut, and hindgut, respectively), the survival curve for CUP was quite similar to that of patients with midgut carcinoids with distant disease (10-year survival of 22% vs 28%).
CONCLUSIONS: CUP are similar to midgut carcinoids presenting with metastatic disease with regard to hormone production and survival. Like other carcinoids, CUP can be an indolent disease process with gradual progression over decades.

Entities:  

Mesh:

Year:  1998        PMID: 9854584     DOI: 10.1067/msy.1998.93105

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  21 in total

1.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  Limitations of somatostatin scintigraphy in primary small bowel neuroendocrine tumors.

Authors:  Jessica E Maxwell; Scott K Sherman; Yusuf Menda; Donghong Wang; Thomas M O'Dorisio; James R Howe
Journal:  J Surg Res       Date:  2014-05-21       Impact factor: 2.192

3.  Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin.

Authors:  Thomas W Czeczok; Kristen M Stashek; Jessica E Maxwell; Thomas M O'Dorisio; James R Howe; Jason L Hornick; Andrew M Bellizzi
Journal:  Appl Immunohistochem Mol Morphol       Date:  2018-02

4.  Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases.

Authors:  P Bhosale; A Shah; W Wei; G Varadhachary; V Johnson; V Shah; V Kundra
Journal:  Eur Radiol       Date:  2012-08-30       Impact factor: 5.315

5.  Severe Unresponsive Hypoglycemia Associated with Neuroendocrine Tumor of Unknown Primary Site - 18 Years after Rectal Cancer Surgery. Case Report.

Authors:  Octavia Cristina Rusu; Radu Virgil Costea; Cristian Constantin Popa; Andreea Iliesiu; Adrian Dumitru; Gabriel Becheanu; Stefan Ilie Neagu
Journal:  Maedica (Bucur)       Date:  2015-09

6.  Imaging in neuroendocrine tumors: an update for the clinician.

Authors:  Jessica E Maxwell; James R Howe
Journal:  Int J Endocr Oncol       Date:  2015

7.  Cushing's Syndrome Caused by a Well-Differentiated Ileal Neuroendocrine Carcinoma.

Authors:  Isabelle Valo; Vincent Rohmer; Serge Guyetant; Jean-Francois Martin; Sophie Venault; Jean-Paul Saint-Andre
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

8.  SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors.

Authors:  Zhongwu Li; Jing Yuan; Lixin Wei; Lixin Zhou; Kaiyong Mei; Junqiu Yue; Hongwen Gao; Miao Zhang; Ling Jia; Qiang Kang; Xiaozheng Huang; Dengfeng Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 9.  Primary neuroendocrine tumor of the sacrum: case report and review of the literature.

Authors:  Fanny Dujardin; Pauline Beaussart; Anne de Muret; Philippe Rosset; Eric Waynberger; Denis Mulleman; Gonzague de Pinieux
Journal:  Skeletal Radiol       Date:  2009-04-10       Impact factor: 2.199

10.  Ga-68 DOTANOC PET/CT imaging in detection of primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India.

Authors:  Ankur Pruthi; Promila Pankaj; Ritu Verma; Anjali Jain; Ethel S Belho; Harsh Mahajan
Journal:  J Gastrointest Oncol       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.